On the origin and the consequences of circadian abnormalities in patients with cirrhosis

American Journal of Gastroenterology

Volumn 105, Issue 8, 2010, Pages 1773-1781

  Montagnese, Sara ^a,c   Middleton, Benita ^b   Mani, Ali R ^a   Skene, Debra J ^b   Morgan, Marsha Y ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; MELATONIN;

ACTIMETRY; ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY POSTURE; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LIVER CIRRHOSIS; MALE; METABOLISM; METABOLITE; PLASMA; POPULATION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SLEEP DISORDER; SLEEP WAKING CYCLE; VOLUNTEER;

ACTIGRAPHY; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYDROCORTISONE; LIKELIHOOD FUNCTIONS; LIVER CIRRHOSIS; MALE; MELATONIN; MIDDLE AGED; SLEEP DISORDERS; STATISTICS, NONPARAMETRIC;

EID: 77955427290     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.86     Document Type: Article

References (39)

1. Czeisler CA, Duffy JF, Shanahan TL et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999; 284: 2177-2181
2. Lewy AJ, Wehr TA, Goodwin FK et al. Light suppresses melatonin secretionin humans. Science 1980; 210: 1267-1269
3. Czeisler CA, Shanahan TL, Klerman EB et al. Suppression of melatoninsecretion in some blind patients by exposure to bright light. N Engl J Med1995; 332: 6-11.
4. Jepson JB, Zaltzman P, Udenfriend S. Microsomal hydroxylation of tryptamine,indoleacetic acid and related compounds, to 6-hydroxy derivatives.Biochim Biophys Acta 1962; 62: 91-102.
5. Bojkowski CJ, Arendt J, Shih MC et al. Melatonin secretion in humans assessedby measuring its metabolite, 6-sulfatoxymelatonin. Clin Chem 1987; 33: 1343-1348
6. C ó rdoba J, Cabrera J, Lataif L et al. High prevalence of sleep disturbance incirrhosis. Hepatology 1998; 27: 339-345
7. Mostacci B, Ferlisi M, Baldi AA et al. Sleep disturbance and daytimesleepiness in patients with cirrhosis: a case control study. Neurol Sci2008; 29: 237-240
8. Montagnese S, Middleton B, Skene DJ et al. Night-time sleep disturbance isnot a feature of hepatic encephalopathy. Liver Int 2009; 29: 1372-1382
9. Steindl PE, Finn B, Bendok B et al. Disruption of the diurnal rhythm ofplasma melatonin in cirrhosis. Ann Intern Med 1995; 123: 274-277
10. Velissaris D, Karanikolas M, Kalogeropoulos A et al. Pituitary hormonecircadian rhythm alterations in cirrhosis patients with subclinical hepaticencephalopathy. World J Gastroenterol 2008; 14: 4190-4195
11. Steindl PE, Ferenci P, Marktl W. Impaired hepatic catabolism of melatoninin cirrhosis. Ann Intern Med 1997; 127: 494.
12. Iguchi H, Kato KI, Ibayashi H. Melatonin serum levels and metabolicclearance rate in patients with liver cirrhosis. J Clin Endocrinol Metab1982; 54: 1025-1027
13. Piscaglia F, Hermida RC, Siringo S et al. Cirrhosis does not shift the circadianphase of plasma fibrinolysis. Am J Gastroenterol 2002; 97: 1512-1517
14. Pugh RN, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagusfor bleeding oesophageal varices. Br J Surg 1973; 60: 646-649
15. Buysse DJ, Reynolds CF III, Monk Thet al. The Pittsburgh Sleep QualityIndex: a new instrument for psychiatric practice and research. PsychiatryRes 1989; 28: 193-213.
16. Lockley SW, Skene DJ, Arendt J. Comparison between subjective and actigraphicmeasurement of sleep and sleep rhythms. J Sleep Res 1999; 8: 175-183
17. Arendt J, Middleton B, Williams P et al. Sleep and circadian phase in aship's crew. J Biol Rhythms 2006; 21: 214-221
18. Aldhous ME, Arendt J. Radioimmunoassay for 6-sulphatoxymelatonin inurine using an iodinated tracer. Ann Clin Biochem 1988; 25: 298-303.
19. Minors DS, Waterhouse JM. Mathematical and statistical analysis of circadianrhythms. Psychoneuroendocrinology 1988; 13: 443-464
20. Lockley SW, Skene DJ, Tabandeh H et al. Relationship between napping andmelatonin in the blind. J Biol Rhythms 1997; 12: 16-25.
21. Vakkuri O, Leppaluoto J, Vuolteenaho O. Development and validation ofa melatonin radioimmunoassay using radioiodinated melatonin as tracer.Acta Endocrinol (Copenh) 1984; 106: 152-157
22. Read GF, Fahmy DR, Walker RF. Determination of cortisol in humanplasma by radioimmunoassay. Use of the 125I-labelled radioligand. AnnClin Biochem 1977; 14: 343-349
23. Lockley SW, Skene DJ, James K et al. Melatonin administration canentrain the free-running circadian system of blind subjects. J Endocrinol2000; 164: R1-6.
24. Gogenur I, Ocak U, Altunpinar O et al. Disturbances in melatonin, cortisoland core body temperature rhythms aft er major surgery. World J Surg2007; 31: 290-298 (Pubitemid 46183512)
25. Duffy JF, Zeitzer JM, Rimmer DW et al. Peak of circadian melatoninrhythm occurs later with in the sleep of older subjects. Am J Physiol EndocrinolMetab 2002; 282: E297-303.
26. Herljevic M, Middleton B, Th apan K et al. Light-induced melatonin suppression:age-related reduction in response to short wavelength light. ExpGerontol 2005; 40: 237-242
27. Th apan K, Arendt J, Skene DJ. An action spectrum for melatonin suppression:evidence for a novel non-rod, non-cone photoreceptor system inhumans. J Physiol 2001; 535: 261-267
28. Bernardi M, De Palma R, Trevisani F et al. Chronobiological study of factorsaffecting plasma aldosterone concentration in cirrhosis. Gastroenterology1986; 91: 683-691
29. Redfern PH, Waterhouse JM, Minors DS. Circadian rhythms: principlesand measurement. Pharmacol Ther 1991; 49: 311-327
30. Boivin DB, Czeisler CA. Resetting of circadian melatonin and cortisolrhythms in humans by ordinary room light. Neuroreport 1998; 9: 779-782
31. Wehr TA. Effect of seasonal changes in daylength on human neuroendocrinefunction. Horm Res 1998; 49: 118-124
32. Middleton B, Arendt J, Stone BM. Human circadian rhythms in constantdim light (8 lux) with knowledge of clock time. J Sleep Res 1996; 5: 69-76.
33. Eckstein AK, Reichenbach A, Jacobi P et al. Hepatic retinopathia. Changesin retinal function. Vision Res 1997; 37: 1699-1706
34. Lockley SW, Dijk DJ, Kosti O et al. Alertness, mood and performancerhythm disturbances associated with circadian sleep disorders in the blind.J Sleep Res 2008; 17: 207-216
35. Butterworth RF. The neurobiology of hepatic encephalopathy. Semin LiverDis 1996; 16: 235-244
36. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadianrhythms. Nature 2005; 437: 1257-1263
37. Boggild H, Knutsson A. Shift work, risk factors and cardiovascular disease.Scand J Work Environ Health 1999; 25: 85-99.
38. Schernhammer ES, Laden F, Speizer FE et al. Rotating night shift s and riskof breast cancer in women participating in the nurses health study. J NatCancer Inst 2001; 93: 1563-1568
39. Montagnese S, Middleton B, Mani AR et al. Sleep and circadian abnormalitiesin patients with cirrhosis: features of delayed sleep phase syndrome?Metab Brain Dis 2009; 24: 427-439